Cybin Inc. (NASDAQ:HELP)
Old Forum Content for HELP
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Mikev200: $Help. Where can I find if I accidently blocked a user??
- phgruver: @Mikev200 $Help Go "Full Screen", and you should see a list of "My hidden users" at the lower left.
- phgruver: @phgruver $Help ...sorry, I'm a bit dyslexic ..., it's the lower right.
- Mikev200: @phgruver $Help AHHHH FULL screen Thank you! Found it
- woodman: @Mikev200 $Help - Mike, also log out and log back in. Sometimes the unintentional blockings will all clear out if you do that.
- bRobert: @scottto_2 I appreciate any $help I can get
- scottto_2: @bRobert $help - Just ask. There's a guy named Robert who's really helpful about technicals, fyi...
- tjv821: Need $help keep on selling my stocks and they keep on going ie $ichr $kem but have huge profits in $ctrp and give it bk over a three day pull back?? Down want to give bk my profits
- issues: @career2 I prefer FB since they make a profit. $YELP needs $HELP. We hold $VLO and $FANG.
| Stock Price | $4.64 |
| Change | -9.55% |
| Volume | 1,581,140 |
Helus Pharma, originally founded as Cybin Inc. in 2019, is a clinical-stage pharmaceutical company committed to helping minds heal by developing proprietary novel serotonergic agonists (NSAs); synthetic molecules designed to activate serotonin pathways believed to promote neuroplasticity. Helus' NSAs are intended to address the significant unmet needs of people living with depression, anxiety, and other mental health conditions. With class-leading clinical data, Helus Pharma aims to advance the mental health treatment landscape through therapies designed to deliver durable improvements. The Company is developing HLP003, a proprietary NSA in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received FDA Breakthrough Therapy Designation, and HLP004, a proprietary NSA in Phase 2 development for generalized anxiety disorder. Helus also maintains a robust research portfolio of investigational NSAs.
Request Video of HELPAlready a member? Sign in here.
Past Month
Leading Peers
-
$6.36 78.19%
-
$10.23 77.99%
-
$77.86 49.46%
Past Month
Lagging Peers
-
$9.23 -33.01%
-
$28.00 -30.22%
-
$21.99 -24.59%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!